BPG is committed to discovery and dissemination of knowledge
Letter to the Editor
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Dec 7, 2025; 31(45): 114413
Published online Dec 7, 2025. doi: 10.3748/wjg.v31.i45.114413
Machine learning to predict metabolic-associated fatty liver disease
Ottavia Cicerone, Marcello Maestri
Ottavia Cicerone, Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia 27100, Italy
Marcello Maestri, General Surgery Unit I - Liver Service, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy
Author contributions: Maestri M contributed to the project administration; Cicerone O and Maestri M contributed to the concept and design of the study, the writing of the original draft and the review and editing of the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Marcello Maestri, MD, PhD, Professor, General Surgery Unit I - Liver Service, Fondazione IRCCS Policlinico San Matteo, P.le Golgi 19, Pavia 27100, Italy. m.maestri@smatteo.pv.it
Received: September 18, 2025
Revised: September 29, 2025
Accepted: October 28, 2025
Published online: December 7, 2025
Processing time: 76 Days and 13.2 Hours
Core Tip

Core Tip: Machine learning can enhance early detection of metabolic-associated fatty liver disease by integrating biochemical, clinical, and traditional Chinese medicine features into predictive models. Tian et al provide a promising framework, though external validation and refinement for disease heterogeneity are needed before widespread clinical adoption.